OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C

OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank gettex Düsseldorf Lang & Schwarz München Stuttgart XETRA QuotrixWichtige Stammdaten
Emittent | OSSIAM |
Auflagedatum | 10.11.2017 |
Kategorie | Aktien |
Fondswährung | EUR |
Benchmark | |
Ausschüttungsart | Thesaurierend |
Total Expense Ratio (TER) | 0,17 % |
Fondsgröße | 238.422.996,74 |
Replikationsart | Physisch vollständig |
Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
---|---|---|---|---|---|---|
Performance | +4,08 % | +11,31 % | +5,36 % | +38,52 % | +67,80 % | +7,69 % |
Outperformance ggü. Kategorie | -0,38 % | -5,40 % | -4,14 % | +0,14 % | +18,77 % | -6,12 % |
Max Verlust | - | - | -10,19 % | -11,63 % | -25,57 % | - |
Kurs | 165,62 € | 148,38 € | 164,28 € | - | - | 173,64 € |
Hoch | - | - | 177,04 € | - | - | - |
Tief | - | - | 146,75 € | - | - | - |
Kennzahlen ISIN: LU1655103486
Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
---|---|---|---|---|
Volatilität | 11,28 % | 10,56 % | 12,83 % | |
Sharpe Ratio | -0,07 | +0,77 | +0,72 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
Name | ISIN | Marktkapitalisierung | Gewichtung |
---|---|---|---|
Novartis AG Registered Shares | CH0012005267 | 214.391.964.115 € | 4,92 % |
AstraZeneca PLC | GB0009895292 | 225.644.452.580 € | 4,80 % |
Nestle SA | CH0038863350 | 201.513.196.493 € | 4,68 % |
Roche Holding AG | CH0012032048 | 245.231.236.948 € | 4,33 % |
HSBC Holdings PLC | GB0005405286 | 210.769.315.844 € | 4,10 % |
Novo Nordisk AS Class B | DK0062498333 | 225.363.939.631 € | 3,19 % |
Unilever PLC | GB00B10RZP78 | 123.994.280.980 € | 2,99 % |
Rolls-Royce Holdings PLC | GB00B63H8491 | 113.238.419.399 € | 2,22 % |
RELX PLC | GB00B2B0DG97 | 72.396.575.111 € | 2,22 % |
Zurich Insurance Group AG | CH0011075394 | 86.841.142.565 € | 2,05 % |
Summe Top 10 | 35,50 % |
Weitere ETFs mit gleicher Benchmark
ETF | TER | Größe | Perf 1J |
---|---|---|---|
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 238,42 Mio. € | +5,36 % |
iShares MSCI USA ESG Enhanced CTB UCITS ETF EUR Hedged Acc | 0,10 % | 20,52 Mrd. € | +14,22 % |
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C | 0,10 % | 18,38 Mrd. € | +2,54 % |
Amundi Index Solutions - Amundi EUR Corporate Bond ESG UCITS ETF 2 DR - EUR (C) | 0,14 % | 6,50 Mrd. € | +3,85 % |
Vanguard FTSE Developed Europe UCITS ETF | 0,10 % | 5,61 Mrd. € | +13,36 % |